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Moringa oleifera is a tree native to a number of Asian, African, and Central American countries and has been used in traditional
medicine for an assortment of medicinal uses for centuries. Due to bioactive compounds within Moringa leaves, it is believed that
Moringa leaf extract may possess cancer-selective antiproliferative properties. Previous research has been conducted in regards to this
topic, but poor experimental design due to lack of necessary controls limits the legitimacy of anticancer claims. While previous research
has shown that Moringa leaf extract has the potential to kill cancer cells, the research fails to demonstrate the effects of Moringa leaf
extract on healthy cells. In order for anticancer claims to be sufficient and yield the possibility of a future cancer treatment, Moringa
leaf extract must not harm non-cancerous cells. This is essential in order to be considered a cancer-selective killing agent. The current
study was designed using tissue type pairs including both cancerous and non-cancerous cell lines. These cell lines were treated with
increasing concentrations of Moringa leaf extracts. After 48 hours, cell proliferation was measured with CellTiter 96 Aqueous NonRadioactive Cell Proliferation Assay, and statistical analyses were completed. Results showed that the Moringa leaf extract had no
statistically significant effect on either of the breast cell lines, cancerous or non-cancerous. However, the results suggest there is a
statistically significant difference in cell proliferation between the lung cell lines. Low concentrations increased cell proliferation in the
healthy lung cells while having no significant effect on the cancerous lung cells. The effects reversed at higher concentrations. This
could be due to the difference in cell responses between cancerous lung cells and healthy lung cells. Microscopy findings provided
qualitative results that helped determine the method of cell death occurring by cells treated with Moringa leaf extract. Ideally, an
effective cancer treatment would cause cancerous cells to die by apoptosis, rather than necrosis. However, the findings suggest necrosis
is the primary mode of death occurring in the cancerous lung cells, while the cancerous breast cells showed no signs of cell death. This
research contradicts previous findings that Moringa leaf extract is a cancer killing agent; therefore, more research should be completed
to understand these new findings.

Introduction
Moringa oleifera is a hardy tree with small, oval-shaped leaves and a
thin trunk. It grows in dry places and hanging from its branches are large
pods containing young seeds. Moringa is a tree of many names and uses,
for its names range from the horseradish tree and drumstick tree in India,
to the benzolive tree in Haiti; however, the name “Miracle Tree” has
commonly been used1. Moringa has been used in traditional medicine for
centuries, dating back to being used by the ancient Romans and Greeks.
Ayurvedic medicine, one of the world’s oldest holistic healing systems,
claims that Moringa can prevent up to 300 diseases, and aside from
preventative measures, its leaves are capable of curative properties as
well2. The traditional uses of Moringa are great in number, for they
include the treatment of bacterial, fungal, viral, and parasitic issues,
along with asthma, circulatory, digestive, and inflammatory disorders3.
Other targeted ailments include malaria, typhoid fever, arthritis,
hypertension, and diabetes. Because of Moringa’s ability to improve the
immune system, treatment of HIV and AIDS symptoms is also possible2.
All parts of Moringa have been utilized, for even the seeds are capable
of purifying water3. With this vast list of traditional medicinal properties,
it comes as no surprise that Moringa is packed with chemical
components to give it an astounding phytochemistry. The familiar
components that give Moringa its nutritional value are its high amounts
of protein, calcium, iron, fiber, vitamin A, and vitamin B. Due to these
components, Moringa is currently being advertised as a “super food,”
possessing higher nutritional value than other nutritious greens such as
kale. A more in depth look at Moringa’s bioactive compounds in the
leaves reveals what is responsible for its medicinal properties. Moringa
contains glucosinolates and isothiocyanates, both of which have shown
great potential in cancer prevention, for glucosinolates are the naturally
occurring precursor of isothiocyanates. While the exact mode of action is
unknown, research has shown that isothiocyanates are a cancer-killing
agent4,5.
A number of Moringa cancer studies have been published by
researchers with experimental results that conclude by saying Moringa
has anticancer activity6,7,8,2. But after deeper review of the conducted
studies, it is apparent that no negative controls were used 7,8. While it has
been shown that Moringa leaf extract has anticancer activity, there is no
evidence that the same leaf extract would not also kill healthy cells. The
research is merely showing that at a specified concentration of Moringa
leaf extract, cancer cells will not survive as well as if they were not

treated with the extract. This is an insignificant claim; if healthy cells are
killed or damaged at the same rate, Moringa leaf extract has no potential
of possibly being developed into a cancer drug. Also, controls must be
conducted regarding the extract solvent used. The solvent without leaf
extract must be applied to the cells to affirm that the solvent is not
producing the anticancer effect. Another aspect to consider to determine
the possibility of Moringa as a cancer treatment is the type of cell death
that results, whether it be apoptosis or necrosis. Apoptotic cells undergo
shrinking, nuclear condensation, and disconnect from neighboring cells
or extracellular matrix. By achieving this sort of cell death, the outside
environment is left unaffected. Necrosis, however, is considered to be an
“accidental” cell death that is uncontrollable and lacks order. When
cancer cells undergo necrosis, the cell membrane is disrupted in a way
that results in the intracellular components being released into the
surrounding cellular environment. This release of material will lead to an
inflammatory response by immune cells, which could possibly lead to
further tumor growth9. In light of this information, it is important to test
the programmed cell death being achieved by the cancer cells in
experimentation. More research is needed in determining whether or not
Moringa leaf extract is cancer-selective in its antiproliferative properties
and if it could serve as a possible cancer treatment in the future.

Methods
Plant materials
Moringa oleifera seeds were generously provided by Dr. Jed Fahey from
Johns Hopkins University. The seeds were cultivated according to the
standards recommended by his lab. The seeds were planted in a soil
mixture containing a 2:1 ratio of potting soil to sand. The plants grew in
an environmental chamber with 15 hours of light per day at 29 oC. The
plants were lightly sprayed with water once a day. Two weeks after
planting, the sprouts were transferred to a larger container for optimal
room for growth. Two months after planting, all viable, healthy leaves
were stripped from the plants and placed in a specimen bag to dry in a
vented chamber for one week. After drying, the leaves were ground with
a mortar and pestle until reaching the consistency of a fine powder. A
second source of Moringa oleifera leaf powder was obtained from Kuli
Kuli, a Moringa provider with research-grade Moringa leaf powder.
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Extraction
Moringa leaf powder (MOL) in the amount of 3.74 g was extracted by a
Soxhlet apparatus with 95% ethanol. The extraction ran for 8 hours until
all soluble constituents had dissolved in the solvent. A rotary evaporator
was then used to evaporate the solvent at 60oC. Moringa leaf extract was
collected at an amount of 0.4 g. The extraction procedure was repeated
with the Kuli Kuli Moringa leaf powder (MOP). From the solid extract
collected, a 5 mg/mL stock solution was made for each Moringa extract
with a 95% ethanol solvent.

Non-Radioactive Cell Proliferation Assay. A Levene’s test was
calculated using JASP, version 0.7.5.5. Two-way ANOVAs with
Bonferroni posttests were calculated using GraphPad Prism. Differences
were considered statistically significant when p values were ≤ 0.05.

Microscopic imaging
Cells were passed and resuspended in media at a concentration of 10,000
cells/133 μL media. Cells were plated in an 8 well chamber slide and
incubated for 24 hours at 37oC. Cells were then treated with 67 μL of 50
μg/mL and 300 μg/mL MOL extract concentrations and ethanol controls
and left to incubate for another 24 hours at 37oC. MOL extract-treated
wells and control wells were stained with Biotium’s Apoptosis,
Necrosis, and Healthy Cell Quantification Kit following the protocol
given in the product information. Cell plates were then imaged with a
Nikon TiEclipse Inverted Microscope.

Evaluation of cell death
Cell staining and microscopic imaging allowed for cell death to be
evaluated in each of the cell lines at the lowest and highest
concentrations of MOL extract. Although these results are not
quantitative, the information can help paint a larger picture of what may
be happening to the cells after the addition of the MOL extracts. The
MCF-10A cells appeared to die primarily by apoptosis at 50 μg/mL of
MOL extract, while dying primarily by necrosis at 300 μg/mL of MOL
extract (Figure 5). These findings suggest that although an overall
change in cell number is not observed due to increasing concentrations
of MOL extract (Figure 2), the method of cell death may be changing as
the concentration of MOL extract increases. The MDA-MB-231 cells
appeared healthy with limited cell death occurring at both concentrations
of MOL extract (Figure 5).
At 50 μg/mL of MOL extract, the NL20 cells revealed a much
smaller percentage of cell death occurrence than the NL20 cells treated
with 300 μg/mL of MOL extract (Figure 6). These findings match the
proliferation data that showed that NL20 cells had greater proliferation
at low concentrations of MOL extract and less proliferation at high
concentrations of MOL extract (Figure 4). The cell death experienced by
NL20 cells at 300 μg/mL of MOL extract also appeared to be occurring

Results

The effects of Moringa oleifera leaf extract were tested on MDA-MB231, MCF-10A, A549, and NL20 cell proliferation. An initial Levene’s
test showed there was unequal variance in the conditions. Because this
Cell culture: A549/NL20 and MDA-MB-231/MCF-10A
The human lung cell carcinoma cell line A549 (ATCC no. CRM-CCL- violated an assumption of ANOVA, the ANOVA was run with the
185) was cultured in DMEM, containing 10% fetal bovine serum (FBS) understanding that there was the potential for inflated type I errors.
and 100 μg/mL gentamicin. The human lung cell line NL20 (ATCC no.
CRL-2503) was cultured in Hams F12 media which includes 1.2 g/L Effects of MOL and MOP extracts on breast cell proliferation
sodium bicarbonate, 1.8 g/L glucose, and 1mM L-glutamine. Other The raw absorbance values of the MDA-MB-231 and MCF-10A cell
added chemicals include 1.5g/L sodium bicarbonate, 2.7 g/L glucose, lines treated with MOL and MOP extracts showed no identifiable trends
200 mM L-glutamine, 10mM nonessential amino acids, 100mg/mL in cell proliferation (Figure 1).
An ANOVA was completed on fold change values for treatment of
insulin, 10mg/mL transferrin, 100% FBS, 0.1 μg/μL epidermal growth
factor, 5 μg/μL hydrocortisone, and 100μg/mL gentamicin. The human MOL and MOP extracts on MDA-MB-231 and MCF-10A, showing no
breast cell carcinoma cell line MDA-MB-231 (ATCC no. CRM-HTB- statistical significance at any of the extract concentrations (p > 0.05).
26) was cultured in RPMI, containing 10% FBS. The human breast cell There were also no identifiable trends in cell proliferation that could be
line MCF-10A (ATCC no. CRL-10317) was cultured in DMEM, observed in either breast cell line (Figure 2).
containing 5% horse serum, 20 ng/mL EGH, 0.5 mg/mL hydrocortisone,
100 ng/ml cholera toxin, 10 μg/mL insulin, and 5.0 mL pen/strep. All Effects of MOL and MOP extracts on lung cell proliferation
The raw absorbance values of the A549 and NL20 cell lines treated with
cell lines were grown at 37oC with 5% CO2.
MOL and MOP extracts showed that increasing amounts of ethanol had
a negative effect on cell proliferation in A549 cells, but when in
Dilution of extracts
The 5 mg/mL stock solution of MOL extract was diluted to achieve final combination with Moringa, cell number increases (Figure 3). It was also
concentrations of 300 μg/mL, 200 μg/mL, 100 μg/mL, and 50 μg/mL evident that the NL20 cell line responded differently to the CellTiter 96
with A549, NL20, MDA-MB-231, and MCF-10A media. The 5 mg/mL Aqueous Non-Radioactive Cell Proliferation Assay than the A549 cell
stock solution from the MOP extract was also diluted with each cell line, by producing much lower absorbance values (Figure 3). The
media to the same concentrations. To serve as a negative control, similar absorbance differences between cell lines can be accounted for by
dilutions with the cell types’ respective medias were made using 95% calculating fold change values.
An ANOVA for treatment of MOL and MOP extracts on fold
ethanol solvent in place of Moringa extracts.
change values of A549 cells revealed no statistical significance at any of
the extract concentrations (p > 0.05). Although the A549 data lacked
Proliferation assay
Four 96 well plates were used to plate 39 wells of each cell type per statistical significance, there was an upward trend in cell proliferation
plate at 5000 cells/200 μL media. The plates were then placed in with increasing concentration of MOL and MOP extract. At 50 and 100
incubation overnight at 37oC. After incubation, the cells were treated in μg/mL of MOL and MOP extracts, the fold change of A549 cell
triplicates with each of the MOL and MOP extract concentrations and proliferation did not differ from the control. However, at 200 and 300
μg/mL of MOL and MOP extracts, the fold change of A549 cell
ethanol controls. The plates were left to incubate for 48 hours at 37oC.
After 48 hours of incubation, the 96 well plates were spun at 600g proliferation doubled that of the control (Figure 4).
An ANOVA for treatment on NL20 cells revealed significance at 50
for one minute. Media was removed, and 100 μL of fresh media was
added to each well to remove any spectrophometric differences due to μg/mL of MOL extract (p ≤ 0.001), 50 μg/mL of MOP extract (p ≤
the extract additions. The CellTiter 96 Aqueous Non-Radioactive Cell 0.05), and 100 μg/mL of MOP extract (p ≤ 0.001) with a fold change
Proliferation Assay was used according to its protocol, and the plates reaching heights of nine times the control. The two highest
were incubated for 3.5 hours. The 96 well plates were then read on a concentrations of MOL extract and MOP extract on NL20 cells showed
plate reader at 490 nm, data was collected, and background values were no statistical significance with cell proliferation measuring below the
control (Figure 4).
subtracted.

Statistical calculation
Fold changes from the average control value were calculated from the
raw data and used in all statistical calculations, where fold change was
the absorbance of treatment divided by the average absorbance of the
ethanol control. Fold change values accounted for the effects of the
ethanol in the MOL and MOP extracts on cell proliferation, so that the
effect of Moringa on cell proliferation could be observed, rather than the
effect of Moringa and ethanol in combination. Fold change values also
allowed for the direct comparison of cell lines that responded differently
in degree of color change to the application of the CellTiter 96 Aqueous
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Figure 1. Raw absorbance values of MDA-MB-231 and MCF-10A
with increasing MOL and MOP extract concentrations compared to
ethanol controls.

Figure 4. Fold change of A549 and NL20 with increasing
MOL and MOP extract concentrations. * p<0.05, ** p<0.01,
by apoptosis, not necrosis (Figure 6). The A549 cells appeared to show
increasing amounts of necrosis with increasing concentrations of MOL
extract (Figure 6).

Discussion

Figure 2. Fold change of MDA-MB-231 and MCF-10A with increasing
MOL and MOP concentrations. * p<0.05, ** p<0.01, *** p<0.001

Figure 3. Raw absorbance values of A549 and NL20 with increasing
MOL and MOP extract concentrations compared to ethanol controls.

A violation of the Levene’s test presents a possible limitation of this
study’s findings, suggesting that the significance found by the ANOVAs
could be a result of false positive results. However, data trends are
evident, suggesting that the cell proliferation data collected in this study
indicates that low concentrations of Moringa leaf extract increase
healthy cell proliferation, especially evident in healthy lung cells (Figure
4). The images gathered by microscopic imaging showed that death in
healthy cells at low MOL extract concentrations occurs by apoptosis or
not all (Figures 5 and 6). In regards to method of cell death, apoptosis is
preferred to necrosis because it prevents the outward environment of the
dying cell from being affected. High concentrations of Moringa leaf
extract decreased cell proliferation in healthy lung cells (Figure 4),
suggesting that there may be a window of optimal concentration of
Moringa leaf extract on healthy cells. In cancer cell lines, low levels of
Moringa leaf extract did not have a significant effect on cancerous breast
cells or cancerous lung cells (Figures 2 and 4). In fact, cancerous lung
cells showed a steady increase in cell proliferation with increasing
concentrations of MOL and MOP extracts (Figure 4), refuting the
likelihood that Moringa could serve as a cancer-killing agent.
Microscopic imaging of cancerous cells also did not show promising
results for the use of Moringa as a cancer treatment option, for cell death
did not appear to be occurring at all in the cancerous breast cells (Figure
5). These findings contradict a similar study that treated the same
cancerous breast cell line, MDA-MB-231, with Moringa leaf extract and
found “significantly low” cell survival above 250 μg/mL due to the
induction of apoptosis7. Cell death in A549 cells suggests that necrosis is
the primary mode of death with increasing concentration of MOL extract
(Figure 6). This finding would also discredit the use of Moringa as a
cancer-killing agent because cancer cell death achieved by necrosis
would yield an inflammatory response and possible further tumor
growth. When comparing the difference between MOL and MOP
extracts on cell proliferation, no statistically significant differences were
found (Figures 2 and 4).
Research previously reported has made contradictory conclusions to
the ones made in this study. Although Al-Asmari et al.’s research using
cancerous breast cells could not be reproduced, similar results were
observed in the cancerous lung cells. However, different conclusions can
be drawn because of the inclusion of ethanol controls. Corrected
absorbance values of A549 cells showed that cell number decreased with
increasing amounts of MOL and MOP extracts (Figure 3), which could
suggest the conclusion that Moringa is resulting in decreased cancer cell
proliferation. The inclusion of an ethanol control, however, showed that
ethanol was also having an effect on cell proliferation. As ethanol
percentage increased, cell number decreased (Figure 3). With the
addition of Moringa, cell number increased above that of the control, a
conclusion that could only be made with the use of fold change values.
Al-Asmari et al. failed to account for the effects of ethanol in the
Moringa extracts used, which led to the conclusion that Moringa was

Journal of the South Carolina Academy of Science, [2017], 15(2) | 10

Undergraduate Research Article

Figure 5. Effects of MOL extract addition to breast cell lines, MCF-10A and MDA-MB-231. DAPI - cell
nucleus, FITC - apoptotic cells, and TRITC - necrotic cells.
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Figure 6. Effects of MOL extract addition to lung cell lines, NL20 and A549. DAPI - cell nucleus, FITC apoptotic cells, and TRITC - necrotic cells.
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killing cancer cells, when in reality, Moringa was slightly rescuing the 8. Jung I.L., Lee, J.H., & Kang, S.C. 2015. A potential oral anticancer
drug candidate, Moringa oleifera leaf extract, induces the apoptosis
cells from the harmful effects of ethanol. Future research should be
conducted to determine why ethanol had such harmful effects on
of human hepatocellular carcinoma cells. Oncology Letters, 10(3),
cancerous lung cells while breast cells were unharmed. The difference in
1597-1604. doi:10.3892/ol.2015.3482
proliferation response to ethanol between the lung and breast cell lines 9. Ouyang, L., Shi, Z., Zhao, S., Wang, F., Zhou, T., Liu, B., & Bao, J.
suggests a significant difference between the two cell lines.
2012. Programmed cell death pathways in cancer: a review of
Past research has also shown that Moringa leaf extract results in a
apoptosis, autophagy and programmed necrosis. Cell Proliferation,
reduction of cancer cell growth, while not comparing the treatment of
45(6), 487-498. doi:10.1111/j.1365-2184.2012.00845.x
Moringa leaf extract on normal cells7,8. One study found that Moringa
leaf extract “showed greater cytotoxicity for tumor cells than for normal
cells”6, but this finding was also contradicted (Figures 2 and 4). One
explanation lies in a dilemma that has been faced by the scientific
community in recent years, a reproducibility crisis. An alarmingly high
percentage of high-impact preclinical cancer papers have been unable to
be replicated, and questions have begun to arise as to whether research
experiments do not possess adequate controls or if the integrity of
researchers should be in question. Although the purpose of this study is
not to question the motives of other scientists, the contradictory results
found may merit future attempts at reproducibility in research.
The results of this study do not support the use of Moringa leaf
extract as a cancer-killing agent or future cancer treatment option;
however, this does not discredit the use of Moringa for other medicinal
uses. The increase in cell proliferation of normal lung cells at low
concentrations of Moringa leaf extracts reinforces the healing properties
that have been associated with Moringa for centuries, revealing that
Moringa is beneficial to normal cells at appropriate concentrations.
Although Moringa is unlikely to be a cancer-killing agent, it could still
be an effective cancer preventative by increasing normal cell
proliferation and preventing cancer cells from achieving metastatic
growth. Future research in this area should be conducted to determine
the true potential of Moringa oleifera in medicine.
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